AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06476756 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Buteyko techniques
Description: Group B: effect of buteyko techniques will be performed first three days of cardiac rehab phase 1.
Study NCT06221995 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Indirect Calorimetry
Description: Resting energy expenditure measurement
Study NCT06474767 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: P-CGS (Pediatric Collaborative Goal Setting)
Description: Electronic questionnaire sent to participants ahead of a pediatric primary care well child visit, assessing goals for themselves and the child's health with prompt to share with providers during visit
Study NCT05764265 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LTP001
Description: LTP001 will be administered orally once daily in the morning
Study NCT06503263 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Zanubrutinib plus Lenalidomide as Maintenance Therapy
Description: Patients were treated by Zanubrutinib(160mg po bid d1-28) plus Lenalidomide(25mg po qd d1-14) as maintenance therapy until 2 years post chemotherpay
Study NCT06284382 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: High score at Childhood Trauma Questionnaire.
Description: In the presence of early trauma arm, 15 participants are recruited based on a high Childhood Trauma Questionnaire total score.
Study NCT06284382 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Low score at Childhood Trauma Questionnaire.
Description: In the absence of early trauma arm, 15 participants are recruited based on a low Childhood Trauma Questionnaire total score.
Study NCT05495789 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual Reality
Description: A relaxing video will be watched with virtual reality glasses.
Study NCT05495789 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music
Description: Relaxing music will be played by wearing headphones.
Study NCT05679388 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relugolix Pill
Description: A medication used to treat prostate cancer. Relugolix comes as a tablet to take by mouth. It is usually taken with or without food once daily.
Study NCT05679388 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ritonavir
Description: HIV antiviral It can treat HIV infection, which causes AIDS. It does not cure HIV or AIDS, but combinations of drugs may slow the progress of the disease and prolong life.
Study NCT05679388 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: A drug used to treat fungal infections.
Study NCT05697328 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine Pill
Description: One-time 60mg dose given orally between 45-120 minutes prior to hyperbaric oxygen therapy
Study NCT05697328 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: One time dose given orally between 45-120 minutes prior to hyperbaric oxygen therapy
Study NCT06318468 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Nursing health assessment teaching and discussion using humanoid diagrams
Description: The experimental group will receive the nursing health assessment teaching for 50 minutes and discussion using humanoid diagrams for 40 minutes to learn comprehensive nursing assessment.
Study NCT06318468 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Nursing health assessment teaching and discussion using case study
Description: The comparison group will receive the nursing health assessment teaching for 50 minutes and discussion using case study for 40 minutes to learn comprehensive nursing assessment.
Study NCT06046118 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Yellow and red light emitting diode photobiomodulation (Eye Light, Espansione Group, Bologna, Italy)
Description: Each session consists of:~* 1st phase: 300 seconds of continuous Yellow light (eyes closed) + 60 seconds of pulsed Yellow light (eyes opened)~* 2nd phase: 300 seconds of continuous Red light(eyes closed) + 60 seconds of pulsed Red light (eyes opened).~Cycle 1: 8 sessions (two PBM per week for 4 weeks); Cycle 2: 6 sessions (two PBM per week for 3 weeks).
Study NCT06046118 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Mask
Description: Low light emission mask (Sham Mask, Espansione group, Bologna, Italy)
Study NCT05525416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium Nitroprusside
Description: A bolus injection of sodium nitroprusside will be given to lower blood pressure and evaluate baroreflex function.
Study NCT05525416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenylephrine Hydrochloride
Description: A bolus injection of phenylephrine will be given to raise blood pressure and evaluate baroreflex function immediately following the sodium nitroprusside infusion.
Study NCT05525416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phenylephrine Hydrochloride
Description: Investigators will give three incremental doses via brachial artery catheter to observe α1-adrenoreceptor mediated vasoconstriction. This will occur three times throughout the protocol.
Study NCT05525416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Norepinephrine
Description: Investigators will give three incremental doses via brachial artery catheter to observe adrenoreceptor activation. This will occur three times throughout the protocol.
Study NCT05525416 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Isometric Handgrip and Post-Exercise Circulatory Occlusion
Description: Participants will perform 2 minutes of isometric handgrip at 30% maximal voluntary contraction followed by 2 minutes of post-exercise circulatory occlusion to assess the reactivity of the blood vessels to exercise and the metaboreflex.
Study NCT05525416 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Rhythmic Handgrip
Description: Participants will perform 3 minutes of rhythmic handgrip at 25% maximal voluntary contraction to assess the reactivity of blood vessels to dynamic exercise.
Study NCT05525416 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold Pressor Test
Description: Standardized sympathetic stressor involving submersion of the hand in ice-cold water for 3-minutes, aiming to elicit endogenous neurotransmitter release and blood pressure increases.
Study NCT05525416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propranolol Hydrochloride
Description: Local infusion via brachial artery catheterization will occur continuously for the remainder of the study. Propranolol is a beta-adrenergic antagonist and will allow investigation of the role of beta receptors in responses to various stressors. The above phenylephrine, norepinephrine, isometric handgrip, post-exercise circulatory occlusion, and rhythmic handgrip protocols will be repeated under propranolol infusion.
Study NCT05525416 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Phentolamine Mesylate
Description: Local infusion via brachial artery catheterization will occur continuously for the remainder of the study. Phentolamine is an alpha-adrenergic antagonist and will allow investigation the role of alpha receptors in responses to various stressors. It will be continuously infused with propranolol. The above phenylephrine, norepinephrine, isometric handgrip, post-exercise circulatory occlusion, and rhythmic handgrip protocols will be repeated under propranolol infusion.
Study NCT05165667 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: rehabilitation team
Description: The meeting comprised physiotherapist, occupational therapist, rehabilitation nurse, speech and language therapists, social worker, nutritionist, psychologists under the team leader guidance by physiatrist. Respondents of both groups will be assessed to see the effects of treatment at 6 th weeks, 12 th weeks and 24 th weeks. Outcomes will be measured by FIM (Functional independence Measure) scores.
Study NCT05165667 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: rehabilitation team
Description: The meeting comprised physiotherapist, occupational therapist, rehabilitation nurse, speech and language therapists, social worker, nutritionist, psychologists under the team leader guidance by physiatrist. Respondents of both groups will be assessed to see the effects of treatment at 6 th weeks, 12 th weeks and 24 th weeks. Outcomes will be measured by FIM (Functional independence Measure) scores.
Study NCT05814666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Danvatirsen
Description: Danvatirsen is a STAT3 targeting drug.
Study NCT05814666 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab is a monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2
Study NCT05814666 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Pembrolizumab
Description: Pembrolizumab is a monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with PD-L1 and PD-L2
Study NCT05306405 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Vaginal Tablet
Description: Misoprostol alone will be repeated every 4 h in both groups for a maximum of 5 doses, reaching Bishop score >8, rupture of membranes or occurrence of labor pain.~Cervical evaluation will be done using Bishop's score. A score \< 5 will be taken as unfavorable Cervix will be termed as ripped when Bishop's score equal 8 or more.~The endpoint of the study will be initiation of active phase of 1st stage of labor which commence from 6cm to full cervical dilatation
Study NCT06366711 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pregnabit Pro device and PregnaOne platform
Description: Remote CTG device for pregnancy care
Study NCT06366711 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pulsenmore device
Description: Remote ultrasound device for pregnancy care
Study NCT06253351 — intervention group
Intervention type: DEVICE
Intervention: Hybrid closed loop (HCL)
Description: * Control IQ : T-Slim pump with Dexcom G6~* Smartguard : Medtronic 780G pump with Guardian G4S~* Diabeloop : Kaliedo pump with Dexcom G6
Study NCT06442475 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo blood, oral, and/or rectal sample collection
Study NCT06442475 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT or CT
Study NCT06442475 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI
Study NCT06442475 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mosunetuzumab
Description: Given IV
Study NCT06442475 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT
Study NCT06442475 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT06388226 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Leg heat therapy
Description: A sous vide heating immersion circulator heats up the water inside the water tank to 42ºC. A water pump circulates temperature-regulated water through the trousers.
Study NCT06388226 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Leg sham therapy
Description: A sous vide heating immersion circulator heats up the water inside the water tank to 33ºC. A water pump circulates temperature-regulated water through the trousers.
Study NCT05388110 — intervention group
Intervention type: BEHAVIORAL
Intervention: SKY Breath Intervention
Description: Sudarshan Kriya Yoga (SKY) is a breath-based meditative practice that entails a sequence of specific breathing techniques to help practitioners achieve a state of calm alertness. It has offered benefits as a therapeutic option for mild-to-moderate depression and anxiety disorders and as an adjunctive treatment in patients with major depressive disorder, but the neurological mechanism of SKY breath intervention is still not fully understood.
Study NCT04945733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amivantamab
Description: Amivantamab will be administered intravenously.
Study NCT05446129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ezabenlimab
Description: Ezabenlimab
Study NCT05446129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 765063
Description: BI 765063
Study NCT05446129 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab
Study NCT05820581 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mentalisation
Description: Hypomentalisation, hypermentalisation, correct mentalisation, lack of mentalisation
Study NCT06116045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BZ371A 7.5 mg (1.5 ml)
Description: 7.5 mg gel
Study NCT06116045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BZ371A 5.0 mg (1.0 ml)
Description: 5.0 mg gel
Study NCT06116045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BZ371A 2.5 mg (0.5 ml)
Description: 2.5 mg gel
Study NCT06116045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (1.5 ml)
Description: BZ371A-matched placebo
Study NCT06116045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (1.0 ml)
Description: BZ371A-matched placebo
Study NCT06116045 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo (0.5 ml)
Description: BZ371A-matched placebo
Study NCT04873037 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BTL Emsella Chair
Description: The Emsella Chair is a novel high-intensity focused electromagnetic (HIFEM) technology for the treatment of pelvic floor related disorders. HIFEM technology induces deep pelvic floor muscle contractions designed to deliver the equivalent of 11,200 Kegel exercises over 28 minutes. The treatment paradigm consists of 3 different phases. The phases consist of an intense stimulation of the pelvic floor muscles (PFM), which consists of stimulation and relaxation. The repetition of the phases and focused electromagnetic energy delivery leads to pelvic floor stimulation, adaptation, and remodelation.
Study NCT04873037 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham BTL Emsella Chair
Description: The sham treatment will provide some sensation without active HIFEM technology. The programming for the sham treatment will have an amplitude limitation, with the setting below therapeutic level (less than 10%) power.
Study NCT04665999 — intervention group
Intervention type: DEVICE
Intervention: Continuous Glucose Monitor
Description: Data collection only
Study NCT05217498 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Istradefylline
Description: Consume 20mg tablet of istradefylline for 28 consecutive days.
Study NCT05217498 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Istradefylline
Description: Consume 20mg tablet of istradefylline for 28 consecutive days.
Study NCT05217498 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: low oxygen therapy
Description: Breath intermittent low oxygen 4 days/week over 2 consecutive weeks. Intermittent low oxygen consists of 15, 90-second episodes of breathing low oxygen at 10% oxygen with 60-second intervals at 21% oxygen.
Study NCT05217498 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: low oxygen therapy
Description: Breath intermittent low oxygen 4 days/week over 2 consecutive weeks. Intermittent low oxygen consists of 15, 90-second episodes of breathing low oxygen at 10% oxygen with 60-second intervals at 21% oxygen.
Study NCT06359834 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Remimazolam besylate
Description: Patients in this group receives 0.1mg/kg of remimazolam to induce sedation prior to endoscope insertion. Remimazolam 2mg is added in case of inadequate sedation.
Study NCT06359834 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Patients in this group receives 1mg/kg of propofol to induce sedation prior to endoscope insertion. Propofol 20mg is added in case of inadequate sedation.
Study NCT06487988 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: direct conventional laryngoscopy
Description: direct conventional laryngoscopy will be performed with N3 (for females) or N4 (for males) Macintosh laryngoscope blade.
Study NCT06487988 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: fiberoptic guided intubation
Description: fiberoptic guided intubation will be performed.
Study NCT05983965 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tazemetostat
Description: Treatment: On day 1 and day 15 of the first cycle, and day 1 of all following cycles, the subject will have office visit with physical exam, vital signs, and lab tests. The subject will take tazemetostat twice a day by mouth continuously as an outpatient. If continuing on the treatment for more than 6 cycles, visits change to every 3 months.
Study NCT06540742 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Artificial intelligence identifies liver hydatids
Description: Artificial neural network was constructed to automatically identify liver hydatid by using deep learning technology
Study NCT06543745 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low-Resistance Training
Description: The following 6 exercises will be performed in 3 sets of 15-15-15 repetitions, 3 times per week for 12 weeks:~Elbow Flexion, Elbow Extension, Lateral Hip Extensions, Hip Extensions, Knee Extensions, Wall push-ups
Study NCT05367778 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HS-10370
Description: HS-10370 will be administered orally once daily in a continuous regimen
Study NCT05083741 — intervention group
Intervention type: DEVICE
Intervention: Chitogel
Description: post-operative dressing within standard of care
Study NCT05083741 — intervention group
Intervention type: DEVICE
Intervention: Nexfoam
Description: post-operative dressing within standard of care
Study NCT06584968 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: training with visual feedback
Description: Training with visual feedback by comparing the value of the monofilament with the pressure value of the monofilament applied on the precision scale in grams.
Study NCT06584968 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: classical learning
Description: Study of the test with practical applications on the researcher who plays the role of the patient
Study NCT05494788 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CardiolRx
Description: Pharmaceutically produced Cannabidiol
Study NCT06396884 — intervention group
Intervention type: DEVICE
Intervention: Oscillometric intermittent non-invasive blood pressure
Description: The hemodynamic management followed liberal fluid therapy, as determined by the attending anesthetist's discretion
Study NCT06396884 — intervention group
Intervention type: DEVICE
Intervention: ClearSight
Description: The hemodynamic management will be conducted in accordance to a goal-directed fluid therapy (GDFT) utilizing the Clearsight system monitoring.
Study NCT06313515 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcutaneous Spinal Cord Stimulation
Description: Non-invasive electrical stimulation of the spinal cord over the skin
Study NCT06313515 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcutaneous Spinal Cord Stimulation
Description: Non-invasive electrical stimulation of the spinal cord over the skin
Study NCT06313515 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Arm-crank bike exercise
Description: Exercise using an arm-bike to target cardiovascular functioning.
Study NCT06313515 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Arm-crank bike exercise
Description: Exercise using an arm-bike to target cardiovascular functioning.
Study NCT06313515 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham Stimulation
Description: Non-invasive electrical stimulation of a lower extremity muscle group over the skin.
Study NCT04447807 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Metacognitive Training
Description: MCT is a structured, interactive approach that addresses cognitive biases, social cognition, and self-esteem. This study will conducted this intervention using group format, on a weekly basis, with duration of 9 weeks total.
Study NCT04447807 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Treatment as Usual
Description: Patients will continue to receive medical attention in the Bipolar Disorder Program -PROMAN- part of the University of São Paulo Medical School.
Study NCT05377996 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XMT-1660
Description: XMT-1660 will be administered through a vein in your arm or port catheter (intravenously)
Study NCT06060899 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Pneumoperitoneum 14mmHg
Description: Performing surgery in 14mmHg pneumoperitoneum pressure
Study NCT06060899 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pneumoperitoneum 10mmHg
Description: Performing surgery in 10mmHg pneumoperitoneum pressure